{
    "paper_id": "7e8472520ff77977f27f9fa3935e4ed430079016",
    "metadata": {
        "title": "Journal Pre-proof No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease",
        "authors": [
            {
                "first": "Louise",
                "middle": [],
                "last": "Biquard",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Dominique",
                "middle": [],
                "last": "Valla",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Pierre-Emmanuel",
                "middle": [],
                "last": "Rautou",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "Please cite this article as: Biquard L, Valla D, Rautou PE, No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease, Journal of Hepatology (2020), doi: https://",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "Louise BIQUARD 1 , Dominique VALLA 1,2,3 , Pierre-Emmanuel RAUTOU 1 with biopsy proven NASH. Using these datasets, we observed that none of the genes necessary for SARS-CoV-2 infection was differentially expressed between lean or obese controls and patients with simple steatosis or with NASH (Table 1) .",
            "cite_spans": [
                {
                    "start": 66,
                    "end": 67,
                    "text": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "ref_spans": [
                {
                    "start": 293,
                    "end": 302,
                    "text": "(Table 1)",
                    "ref_id": "TABREF1"
                }
            ],
            "section": "No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease"
        },
        {
            "text": "We performed the same analysis in a mouse dataset published by Xiong and colleagues 7 on whole liver RNA-Seq of mice subjected to 36 weeks high fat diet. Similarly, we observed no increase in liver gene expression of the four proteins implicated in SARS-CoV-2 infection between mice with MAFLD mice and control mice (data not shown).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease"
        },
        {
            "text": "In conclusion, MAFLD is not associated with changes in liver expression of genes implicated in SARS-CoV-2 infection. The observed persistence of liver blood test abnormalities reported by Ji and colleagues is thus likely not explained by an increased liver SARS-CoV-2 uptake. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Implication of nonalcoholic fatty liver diseases (NAFLD)",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Ji",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Qin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Lau",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hoffmann",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kleine-Weber",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Schroeder",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kr\u00fcger",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Herrler",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Erichsen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Cell",
            "volume": "181",
            "issn": "",
            "pages": "271--280",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "A pneumonia outbreak associated with a new coronavirus of probable bat origin",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nature",
            "volume": "579",
            "issn": "",
            "pages": "270--273",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Ou",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Lei",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Mi",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Ren",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nat. Commun",
            "volume": "11",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct diseasespecific and remodeling signatures after bariatric surgery",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ahrens",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Ammerpohl",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Von Sch\u00f6nfels",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kolarova",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bens",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Itzel",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Cell Metab",
            "volume": "18",
            "issn": "",
            "pages": "296--302",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Human liver biopsy of different phases from control to NASH",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Jochen",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Andreas",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Timo",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Xiong",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Mol. Metab",
            "volume": "20",
            "issn": "",
            "pages": "128--137",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "This work was supported by the \"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale\" (ATIP AVENIR), the \"Agence Nationale pour la Recherche\" (ANR-18-CE14-0006-01, RHU QUID-NASH ) and by \"\u00c9mergence, Ville de Paris\".2 Authors contributions: L.B. performed the bioinformatic analysis; L.B. and P.E.R. wrote the manuscript; D.V. provided guidance and proof-read the manuscript; with interest the research article published by Ji and colleagues, in the Journal of Hepatology, including 202 patients with confirmed COVID-19 and showing that patient with metabolic associated fatty liver disease (MAFLD) have higher risk of COVID-19 disease progression and higher likelihood of abnormal liver blood tests from admission to discharge than patients without MAFLD 1 . Given the absence of data on medical history of these patients, this persistence of liver blood test abnormalities could be either a mere reflection of pre-existing abnormalities related to MAFLD or could alternatively be due to a higher susceptibility of the fatty liver to SARS-CoV-2 infection. We therefore investigated whether MAFLD is associated with altered liver expression of SARS-CoV-2 critical entry proteins. SARS-CoV-2 attaches to cells via binding to angiotensin converting enzyme 2 (ACE2). The cellular protease Transmembrane Protease Serine 2 (TMPRSS2) cleaves the SARS-CoV-2 spike protein, allowing fusion of cellular and viral membranes 2,3 . Moreover, in the HEK 293 cell line overexpressing human ACE2, SARS-CoV-2 enters through endocytosis with critical roles played by endocytosis-regulating protein Phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) 4 . Finally, as described for SARS-CoV and MERS-CoV, cathepsin L is also critical for priming of SARS-CoV-2 spike protein in lysosomes following entry through endocytosis 4 . We analysed the influence of MAFLD on liver gene expression of these four proteins implicated in SARS-CoV-2 infection by analysing public data from patients and from mice with MAFLD. Ahrens and colleagues published in 2013 microarray data obtained on human liver biopsies 5,6 . They made available transcriptomics data of 12 lean patients without MAFLD, 16 obese patients without MAFLD, 9 patients with simple steatosis and 17 patients 4",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Conflict of interest declaration:The authors declare no conflict of interest.",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "mRNA expression of SARS-CoV-2 infection critical genes in human liver biopsy. Human microarray data 6 was made available by Ahrens and colleagues 5 and reanalysed by us using Geo2R default settings. CSTL gene encodes cathepsin L protein.Human transcriptomics data is available on GEO Dataset under the accession number GSE48452.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}